TuHURA Biosciences, Inc.
HURA
$4.10
-$0.13-3.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 128.47% | -28.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 114.23% | -18.22% | |||
| Operating Income | -114.23% | 18.22% | |||
| Income Before Tax | -123.55% | -22.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -123.55% | -22.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -123.55% | -22.86% | |||
| EBIT | -114.23% | 18.22% | |||
| EBITDA | -116.50% | 18.10% | |||
| EPS Basic | -259.64% | -- | |||
| Normalized Basic EPS | -261.22% | -- | |||
| EPS Diluted | -252.49% | -- | |||
| Normalized Diluted EPS | -261.22% | -- | |||
| Average Basic Shares Outstanding | -37.77% | -- | |||
| Average Diluted Shares Outstanding | -37.77% | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||